Results 171 to 180 of about 107,687,715 (215)

Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors. [PDF]

BMC Microbiol
Popova TG, Millis B, Bradburne C, Nazarenko S, Bailey C, Chandhoke V, Popov SG.   +6 more
europepmc   +1 more source

Association of serum syndecan-1 concentrations with albuminuria in type 2 diabetes. [PDF]

Diab Vasc Dis Res
Kakutani Y, Morioka T, Yamazaki Y, Ochi A, Fukumoto S, Shoji T, Emoto M.   +6 more
europepmc   +1 more source

RBT-1, a "preconditioning" agent, mitigates syndecan-1 shedding in patients undergoing "on pump" cardiac surgery and following experimental AKI. [PDF]

Physiol Rep
Johnson ACM, Zager RA.
europepmc   +1 more source

Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. [PDF]

Cancer Med
Yablecovitch D, Nadler M, Ben-Horin S, Picard O, Yavzori M, Fudim E, Duchan MT, Sakhnini E, Lang A, Lahav M, Saker T, Neuman S, Selinger L, Freitz B, Dvir R, Raitses-Gurevich M, Golan T, Levy I, Laish I.   +18 more
europepmc   +1 more source

Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients. [PDF]

Ital J Pediatr
Dai L, Zhang L, He J, Huang R, Tang W, Guo H, Shang X.   +6 more
europepmc   +1 more source

Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1. [PDF]

EBioMedicine
de Sousa FTG, Warnes CM, Manuli ER, Tjang LV, Carneiro PH, Maria de Oliveira Pinto L, Ng A, Bhat S, Zambrana JV, D'Elia Zanella LGFAB, Ho YL, Romano CM, Beatty PR, Biering SB, Kallas EG, Sabino EC, Harris E.   +16 more
europepmc   +1 more source

The Differentiation Potential of Apical Papilla Cells in Relation to Tenascin-C and Syndecan-1 Expression and Their Potential Role in Regeneration. [PDF]

Int J Dent
Kodonas K, Fardi A, Papadimitriou S, Gogos C.   +3 more
europepmc   +1 more source

Molecular Functions of Syndecan-1 in Disease [PDF]

Matrix Biology, 2012
Syndecan-1 is a cell surface heparan sulfate proteoglycan that binds to many mediators of disease pathogenesis. Through these molecular interactions, syndecan-1 can modulate leukocyte recruitment, cancer cell proliferation and invasion, angiogenesis, microbial attachment and entry, host defense mechanisms, and matrix remodeling.
Pyong Woo Park, Rafael S Aquino
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Syndecan-1 in liver pathophysiology

American Journal of Physiology-Cell Physiology, 2022
Syndecan-1 (SDC-1) is a heparan sulfate (HS)/chondroitin sulfate proteoglycan (PG) of the cell surface and the extracellular matrix (ECM), which regulates a broad spectrum of physiological and pathological processes such as cell proliferation, migration, inflammation, matrix remodeling, wound healing, and tumorigenesis. Syndecan-1 represents the major
Andrea Reszegi, Péter Tátrai, Eszter Regős, Ilona Kovalszky, Kornélia Baghy   +4 more
openaire   +2 more sources

The role of actomyosin in the regulation of syndecan-1 in hyperosmosis

Biochimica et Biophysica Acta (BBA) - General Subjects, 2021
The endothelial glycocalyx is susceptible to high concentration of glucose and sodium in the blood. These challenges often involve an increase in osmotic pressure which may independently alters the glycocalyx components. The glycocalyx anchors on the cell membrane via core proteins that link with the actin cytoskeleton.
Li, W, Wang, W
openaire   +3 more sources